Medical Data Vision Co., Ltd.

As of June 30, 2024, Medical Data Vision Co., Ltd. has 38.20M shares outstanding.

As of June 30, 2024, Medical Data Vision Co., Ltd. trades at a trailing price-to-earnings ratio of 51.15. The price-to-sales ratio is 3.69, and the price-to-book ratio stands at 5.14.

As of June 30, 2024, Medical Data Vision Co., Ltd. trades at an EV/EBITDA multiple of 19.06 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.32 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 19.06 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses.

As of June 30, 2024, Medical Data Vision Co., Ltd. maintains a current ratio of 2.41, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2024, Medical Data Vision Co., Ltd. posted a return on equity (ROE) of 10.27, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 13.20 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 8.00, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 10.73, useful for judging operating efficiency across full business cycles. Inventory turnover of 302.52 indicates how many times Medical Data Vision Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

These figures cover the twelve months ended June 30, 2024. That works out to an effective tax rate of 49.91, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.

As of the close on April 23, 2026, Medical Data Vision Co., Ltd.'s stock has gained approximately 293.46% over the past 52 weeks. The 50-day moving average sits at 1,682.28, while the 200-day moving average is 1,003.55.

Over the twelve months ended June 30, 2024, Medical Data Vision Co., Ltd. posted a gross margin of 76.60, reflecting its pricing power and cost economics. The operating margin of 17.40 and net profit margin of 7.22 provide insight into operational efficiency.

Medical Data Vision Co., Ltd.'s most recent stock split took place on April 25, 2018 with a 1:2 split ratio.

As of June 30, 2024, Medical Data Vision Co., Ltd. has an Altman Z-Score of 11.55, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.